Sections
| Title | Starting Page | Number of Pages |
|---|
| Table of Contents | 2 | 3 |
| List of Tables | 3 | 1 |
| List of Figures | 4 | 1 |
| Active Implants LLC, Medical Equipment, Deals By Year, 2010 to YTD 2016 | 4 | 2 |
| Active Implants LLC, Medical Equipment Deals By Type, 2010 to YTD 2016 | 6 | 1 |
| Active Implants LLC, Medical Equipment, Deals By Region, 2010 to YTD 2016 | 7 | 1 |
| Active Implants LLC, Medical Equipment, Deals By Market, 2010 to YTD 2016 | 8 | 1 |
| Active Implants LLC, Medical Equipment, Deals Summary, 2010 to YTD 2016 | 9 | 1 |
| Active Implants LLC, Medical Equipment, Deal Details | 10 | 4 |
| Venture Financing | 10 | 1 |
| Active Implants Raises US$8.7 Million In First Tranche Of Venture Financing | 10 | 1 |
| Active Implants Raises US$0.6 Million In Venture Financing | 11 | 1 |
| Active Implants Raises Additional US$5.2 Million In Venture Financing | 12 | 1 |
| Active Implants Raises US$10 Million In Venture Financing | 13 | 1 |
| Active Implants LLC - Key Competitors | 14 | 1 |
| Key Employees | 15 | 1 |
| Locations And Subsidiaries | 16 | 1 |
| Head Office | 16 | 1 |
| Other Locations &Subsidiaries | 16 | 1 |
| Recent Developments | 17 | 1 |
| Product News | 17 | 1 |
| Mar 08, 2016: Advanced Orthopaedics Performs Virginia s First Meniscus Replacement with NUsurface Implant | 17 | 1 |
| Feb 09, 2016: Active Implants VENUS Clinical Trial for Persistent Knee Pain Now Underway in Memphis | 18 | 1 |
| Feb 03, 2016: VENUS Clinical Trial for Persistent Knee Pain Now Underway in North Carolina | 19 | 1 |
| Feb 02, 2016: Active Implants Initiates Second Clinical Trial Evaluating NUsurface Meniscus Replacement | 20 | 1 |
| Clinical Trials | 21 | 1 |
| Feb 09, 2016: Active Implants VENUS Clinical Trial for Persistent Knee Pain Now Underway in Memphis | 21 | 1 |
| Feb 03, 2016: VENUS Clinical Trial for Persistent Knee Pain Now Underway in North Carolina | 22 | 1 |
| Feb 02, 2016: Active Implants Initiates Second Clinical Trial Evaluating NUsurface Meniscus Replacement | 23 | 1 |
| Appendix | 24 | 1 |
| Methodology | 24 | 1 |
| About GlobalData | 24 | 1 |
| Contact Us | 24 | 1 |
| Disclaimer | 24 | 1 |